Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating multiple sclerosis.
Researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed a brain imaging technique that reveals how tiny blood vessels in the brain pulse with each heartbeat—changes that may hold clues to aging and diseases such as Alzheimer’s.
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
DENVER, Sept. 24, 2025 /PRNewswire/ — TSC Life announces FDA clearance of its moderate to high flow blood and fluid warmer, Fluido® AirGuard System, in the U.S.
New machine learning models developed by University of South Australia (UniSA) researchers could help clinicians identify when patients can successfully stop long-term antidepressant use.
UK researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy.
Researchers at the University of Minnesota Twin Cities have successfully 3D printed lifelike human tissue structures that can be used for medical training for surgeons and doctors
One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot known as “Amanda” for relationship support shows that a single session of chatbot therapy can be as beneficial as evidence-based journaling in assisting with relationship conflict resolution.